BUCHI J KEVIN Insider Trading
Get the latest insider transactions of BUCHI J KEVIN. BUCHI J KEVIN is Chief Executive Officer in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and Director in IMPAX LABORATORIES INC ($IPXL) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and Director in STEMLINE THERAPEUTICS INC ($STML) and Director in Alexza Pharmaceuticals Inc. ($ALXA) and President & CEO in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Amneal Pharmaceuticals, Inc. ($AMRX). Discover the current value of BUCHI J KEVIN shares.
Address:
BUCHI J KEVIN is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
TLOG | TETRALOGIC PHARMACEUTICALS Corp | President & CEO | 330,714 | 19,842.84 |
CRXX | EPIRUS Biopharmaceuticals, Inc. | Director | 0 | 0.00 |
ALXA | Alexza Pharmaceuticals Inc. | Director | 0 | 0.00 |
STML | STEMLINE THERAPEUTICS INC | Director | 23,772 | 147,386.40 |
IPXL | Impax Laboratories, LLC | Director | 0 | 0.00 |
AMRX | Amneal Pharmaceuticals, Inc. | Director | 70,085 | |
DRNA | Dicerna Pharmaceuticals Inc | Director | 0 | 0.00 |
BSTCE | BIOSPECIFICS TECHNOLOGIES CORP | Chief Executive Officer | 0 | 0.00 |
ZIOP | ZIOPHARM ONCOLOGY INC | Director | 4,167 | 27,918.90 |
Insider Trading Transactions of BUCHI J KEVIN
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
May 07 2021 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Buy | 0.00 | 46,218 | 0 | 70,085 |
May 07 2021 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Option Exercise | 0.00 | 35,406 | 0 | 35,406 |
May 07 2021 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Option Exercise | 0.00 | 46,218 | 0 | 0 |
May 06 2021 | ZIOP | ZIOPHARM ONCOLOGY INC | BUCHI J KEVIN | Director | Buy | 0.00 | 4,167 | 0 | 4,167 |
May 06 2021 | ZIOP | ZIOPHARM ONCOLOGY INC | BUCHI J KEVIN | Director | Option Exercise | 4.31 | 31,250 | 134,688 | 31,250 |
Oct 13 2020 | ZIOP | ZIOPHARM ONCOLOGY INC | BUCHI J KEVIN | Director | Option Exercise | 2.76 | 146,190 | 403,484 | 146,190 |
Jun 16 2020 | DRNA | Dicerna Pharmaceuticals I ... | BUCHI J KEVIN | Director | Option Exercise | 0.00 | 4,666 | 0 | 4,666 |
Jun 16 2020 | DRNA | Dicerna Pharmaceuticals I ... | BUCHI J KEVIN | Director | Option Exercise | 21.61 | 21,000 | 453,810 | 21,000 |
May 07 2020 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Buy | 0.00 | 6,459 | 0 | 23,867 |
May 07 2020 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Option Exercise | 0.00 | 46,218 | 0 | 46,218 |
May 07 2020 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Option Exercise | 0.00 | 6,459 | 0 | 0 |
Oct 25 2019 | BSTCE | BIOSPECIFICS TECHNOLOGIES ... | BUCHI J KEVIN | Chief Executive Offic ... | Option Exercise | 46.52 | 85,000 | 3,954,200 | 85,000 |
Oct 25 2019 | BSTCE | BIOSPECIFICS TECHNOLOGIES ... | BUCHI J KEVIN | Chief Executive Offic ... | Option Exercise | 46.52 | 85,000 | 3,954,200 | 85,000 |
Oct 25 2019 | BSTCE | BIOSPECIFICS TECHNOLOGIES ... | BUCHI J KEVIN | Chief Executive Offic ... | Option Exercise | 46.52 | 85,000 | 3,954,200 | 85,000 |
Jun 21 2019 | DRNA | Dicerna Pharmaceuticals I ... | BUCHI J KEVIN | Director | Option Exercise | 15.44 | 33,000 | 509,520 | 33,000 |
May 08 2019 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Buy | 0.00 | 6,107 | 0 | 17,408 |
May 08 2019 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Option Exercise | 14.05 | 28,044 | 394,018 | 28,044 |
May 08 2019 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Option Exercise | 0.00 | 6,459 | 0 | 6,459 |
May 08 2019 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Option Exercise | 0.00 | 6,107 | 0 | 0 |
Mar 29 2019 | DRNA | Dicerna Pharmaceuticals I ... | BUCHI J KEVIN | Director | Option Exercise | 14.13 | 8,000 | 113,040 | 8,000 |
Aug 15 2018 | DRNA | Dicerna Pharmaceuticals I ... | BUCHI J KEVIN | Option Exercise | 14.76 | 25,000 | 369,000 | 25,000 | |
Aug 15 2018 | DRNA | Dicerna Pharmaceuticals I ... | BUCHI J KEVIN | Option Exercise | 14.76 | 25,000 | 369,000 | 25,000 | |
May 08 2018 | IPXL | Impax Laboratories, LLC | BUCHI J KEVIN | Director | Sell | 0.00 | 8,020 | 0 | 0 |
May 08 2018 | IPXL | Impax Laboratories, LLC | BUCHI J KEVIN | Director | Sell | 0.00 | 3,281 | 0 | 0 |
May 08 2018 | IPXL | Impax Laboratories, LLC | BUCHI J KEVIN | Director | Option Exercise | 16.40 | 7,931 | 130,068 | 0 |
May 08 2018 | IPXL | Impax Laboratories, LLC | BUCHI J KEVIN | Director | Option Exercise | 14.45 | 20,445 | 295,430 | 0 |
May 08 2018 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Buy | 0.00 | 11,301 | 0 | 11,301 |
May 08 2018 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Option Exercise | 16.40 | 7,931 | 130,068 | 7,931 |
May 08 2018 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Option Exercise | 14.45 | 20,445 | 295,430 | 20,445 |
May 08 2018 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Option Exercise | 15.01 | 24,977 | 374,905 | 24,977 |
May 08 2018 | AMRX | Amneal Pharmaceuticals, I ... | BUCHI J KEVIN | Director | Option Exercise | 0.00 | 6,107 | 0 | 6,107 |
May 17 2017 | IPXL | IMPAX LABORATORIES INC | BUCHI J KEVIN | Director | Buy | 0.00 | 3,281 | 0 | 11,301 |
May 17 2017 | IPXL | IMPAX LABORATORIES INC | BUCHI J KEVIN | Director | Option Exercise | 16.40 | 7,931 | 130,068 | 7,931 |
Nov 28 2016 | IPXL | IMPAX LABORATORIES INC | BUCHI J KEVIN | Director | Buy | 0.00 | 8,020 | 0 | 8,020 |
Nov 28 2016 | IPXL | IMPAX LABORATORIES INC | BUCHI J KEVIN | Director | Option Exercise | 14.45 | 20,445 | 295,430 | 20,445 |
Jun 21 2016 | ALXA | Alexza Pharmaceuticals In ... | BUCHI J KEVIN | Director | Option Exercise | 1.28 | 12,500 | 16,000 | 0 |
Jun 21 2016 | ALXA | Alexza Pharmaceuticals In ... | BUCHI J KEVIN | Director | Option Exercise | 4.35 | 12,500 | 54,375 | 0 |
Jun 21 2016 | ALXA | Alexza Pharmaceuticals In ... | BUCHI J KEVIN | Director | Option Exercise | 5.13 | 20,000 | 102,600 | 0 |
Jun 25 2015 | ALXA | Alexza Pharmaceuticals In ... | BUCHI J KEVIN | Director | Option Exercise | 1.28 | 12,500 | 16,000 | 12,500 |
Jun 25 2015 | STML | STEMLINE THERAPEUTICS INC | BUCHI J KEVIN | Director | Buy | 0.00 | 10,000 | 0 | 23,772 |
Jun 25 2015 | STML | STEMLINE THERAPEUTICS INC | BUCHI J KEVIN | Director | Option Exercise | 12.76 | 24,000 | 306,240 | 24,000 |
Jun 08 2015 | CRXX | EPIRUS Biopharmaceuticals ... | BUCHI J KEVIN | Director | Option Exercise | 6.39 | 9,000 | 57,510 | 9,000 |
Mar 30 2015 | TLOG | TETRALOGIC PHARMACEUTICAL ... | BUCHI J KEVIN | President & CEO | Buy | 4.23 | 5,000 | 21,148 | 330,714 |